-
-
-
-
-
-
-
Zai Lab Announces Third Quarter 2025 Financial Results and Recent Corporate Updates
-
-
-
-
-
-
-
Zai Lab to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Recent Corporate Updates on February 27, 2025
-
-
-
-
-
-
-
Zai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024
-
-
-
-
-
-
-
Zai Lab to Announce Full-Year Financial Results and Corporate Updates on March 1, 2023
-
-
-
-
-
-
-
Zai Lab and Novocure Announce EF-31 Phase 2 Pilot Study Evaluating Tumor Treating Fields Together with Standard-of-Care Chemotherapy Meets Primary Endpoint for First-Line Treatment of Gastric Cancer
-
-
-
-
-
-
-
Novocure and Zai Lab Announce Last Patient Enrolled in Phase 2 Pilot Trial of Tumor Treating Fields Plus Chemotherapy as First-Line Treatment in Gastric Cancer in China
-
-
-
-
-
-
-
Zai Lab Partner Novocure Announces Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer
-
1,224,037 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

